Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies Sebastião Cezar Radominski, Mario Humberto Cardiel, Gustavo Citera, Annelise Goecke, Juan Jose Jaller, Andrea Barranjard Vannucci Lomonte, Pedro Miranda, Patricia Velez, Daniel Xibillé, Kenneth Kwok, Ricardo Rojo, Erika Gabriela García

Takotsubo Syndrome in a Rheumatoid Arthritis Patient Under Tofacitinib: A Case Report Salomé Garcia, Georgina Terroso, Elisabete Martins, Sofia Pimenta, Lúcia Costa, Miguel Bernardes

Safety and effectiveness of bDMARDs during pregnancy in patients with rheumatic diseases: Real-world data from the BIOBADASER registry Cristina Membrive-Jiménez, Carlos Sánchez-Piedra, Olga Martínez-González, Javier García-González, Lorena Expósito-Pérez, Cristina Bohórquez-Heras, Cristina Campos-Fernández, Fernando Sanchez-Alonso, Rafael Cáliz-Cáliz, Isabel Castrejón-Fernández